Capital Royalty offers an attractive source of financing for healthcare companies with strong intellectual property assets. Our royalty bonds and other customized royalty monetization structures appeal to CFOs looking to access capital while retaining a stake in the future performance of their royalty streams. Our business partners receive upfront capital to fund near-term projects in exchange for a portion of their future royalty streams.

We aim to provide a more cost-effective and flexible form of capital than typical equity financings.  Our royalty monetizations are non-dilutive and less restrictive than other forms of capital. 

Companies utilize royalty monetization transactions to:

• Finance pipeline development
• Fund product acquisition and in-licensing activities
• Support product launch costs
• Replace or supplement existing capital sources
• Monetize undervalued royalty assets and redeploy capital into projects that provide more value to equity holders
• Ascribe value to intangible intellectual property assets
• Finance acquisitions